As in the LEAN study, the primary outcome is histologic resolution of NASH without worsening of fibrosis after 72 weeks of treatment, while secondary outcomes include improvement in liver fibrosis (1 stage) with no worsening of NASH, NAFLD activity score, as well as multiple serum markers of fibrosis
On average, GLP-1s produce greater total weight loss
Studies have found that those using Semaglutide GLP-1 lost up to 10% of their body weight over a period of 16 weeks, compared to those not using Semaglutide GLP-1, who lost an average of 3%
Based on the route of administration, the cardiovascular drugs market is divided into oral, parenteral, and other route of administration
GLP-1 drugs don't work for everyone
A licensed provider can evaluate whether a modified approach makes sense for your specific situation and can also monitor your progress to ensure youre still moving toward a dose thats actually therapeutic